Publicaciones en colaboración con investigadores/as de Hospital Universitario La Paz (37)

2021

  1. Non-inflammatory causes of emergency consultation in patients with multiple sclerosis

    Neurologia, Vol. 36, Núm. 6, pp. 403-411

  2. Risk and outcomes of COVID-19 in patients with multiple sclerosis

    European Journal of Neurology, Vol. 28, Núm. 11, pp. 3712-3721

2020

  1. Clinical and therapeutic predictors of disease outcomes in AQP4-IgG+ neuromyelitis optica spectrum disorder

    Multiple Sclerosis and Related Disorders, Vol. 38

2019

  1. Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study

    Multiple Sclerosis and Related Disorders, Vol. 28, pp. 235-243

2017

  1. Multimarker risk stratification approach at multiple sclerosis onset

    Clinical Immunology, Vol. 181, pp. 43-50

  2. Towards personalized therapy for multiple sclerosis: Prediction of individual treatment response

    Brain, Vol. 140, Núm. 9, pp. 2426-2443

2016

  1. Intervenciones psicoterapéuticas y psicosociales para el manejo del estrés en esclerosis múltiple: Aportación de intervenciones basadas en mindfulness

    Neurologia

  2. Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus

    Neurology: Neuroimmunology and NeuroInflammation, Vol. 3, Núm. 3

  3. Respuesta al tratamiento con interferón beta en pacientes con esclerosis múltiple. Validación del Rio Score

    Revista de Neurologia, Vol. 63, Núm. 4, pp. 145-150

2015

  1. Male sex is independently associated with faster disability accumulation in relapse-onset MS but not in primary progressive MS

    PLoS ONE, Vol. 10, Núm. 6

2013

  1. Historical changes of seasonal differences in the frequency of multiple sclerosis clinical attacks: A multicenter study

    Journal of Neurology, Vol. 260, Núm. 5, pp. 1258-1262

  2. Monitoring neuromyelitis optica activity.

    Expert review of neurotherapeutics, Vol. 13, Núm. 9, pp. 989-999

2012

  1. Clinical efficacy and effectiveness of Sativex ®, a combined cannabinoid medicine, in multiple sclerosis-related spasticity

    Expert Review of Neurotherapeutics

  2. Clinically isolated syndromes suggestive of multiple sclerosis: An optical coherence tomography study

    PLoS ONE, Vol. 7, Núm. 3

  3. Consenso español sobre la utilización de natalizumab (Tysabri®) - 2011

    Neurologia

  4. Country, sex, edss change and therapy choice independently predict treatment discontinuation in multiple sclerosis and clinically isolated syndrome

    PLoS ONE, Vol. 7, Núm. 6

  5. Geographical Variations in Sex Ratio Trends over Time in Multiple Sclerosis

    PLoS ONE, Vol. 7, Núm. 10

  6. Improving patient-physician dialog: Commentary on the results of the MS Choices survey

    Patient Preference and Adherence

  7. Increasing age at disability milestones among MS patients in the MSBase Registry

    Journal of the Neurological Sciences, Vol. 318, Núm. 1-2, pp. 94-99

  8. Natalizumab treatment of multiple sclerosis in Spain: Results of an extensive observational study

    Journal of Neurology, Vol. 259, Núm. 9, pp. 1814-1823